CAPE CANAVERAL, Fla., Nov. 08, 2023 Vaxxinity, Inc. , a U.S. company pioneering the development of a new class of medicines, today reported financial results for the third quarter ended.
Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.
Vaxxinity Appoints Peter Powchik, M D , to Executive Vice President, Global Scientific Director itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
By Daniella Parra Vaxxinity, Inc. (Nasdaq: VAXX) said it appointed Peter Powchik, M.D. as Executive Vice President, Global Scientific Director overseeing its scientific direction and lead development efforts. Powchik was previously Senior Vice President at Regeneron Pharmaceuticals, the company said. Additionally, Ulo Palm, M.D., will transition from Chief Medical Officer to senior advisor, it said. […]